AzTrials
AzTrials

StrokeAINCT07209592

Effect of Artificial Intelligence Based Gamification Training on Cognition and Functional Outcomes in Patients With Stroke

A study testing AI gamification and conventional therapy in people with Stroke, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

this study will be conducted to investigate the effect of artificial intelligence based gamification training on cognition and functional outcomes in patients with stroke Read more about this study

Who is it for?
Ages 45 to 60 years
Conditions the study is for
Stroke
What is being tested?
AI gamification and conventional therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteEgypt
Study dates
1 Jan 2026to 1 Aug 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Forty hemiplegic patients with mild post stroke cognitive impairment.
  • The patients age will be 45 to 60.
  • Chronic stroke (6 months post-stroke).
  • Score of 1 to 1+ to points on the Modified Ashworth Scale (MAS) on upper limb (shoulder , elbow ,hand).
  • Stage of recovery 4-5 brunnstrom
  • Essential educational level ( at least high school level)
  • BMI will be ranged from 18,5 -24.9 kg\m2

Who cannot join

  • Moderate and severe post stroke cognitive impairment
  • Excluding cognitive impairment for any other psychological or neurological disease such as depression and dementia
  • history of recent upper limb surgery
  • Any musculoskeletal disorders of upper extremity (e.g fractures or injuries)
  • Having a heart pacemaker, pregnancy
  • Other neurological diseases or cancer
  • Hormonal disturbances

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo University,Giza

    Giza

Other trials in Egypt

About this study

this study will be conducted to investigate the effect of artificial intelligence based gamification training on cognition and functional outcomes in patients with stroke

Read the detailed description

Stroke is a neurological disorder characterized by blockage of blood vessels. Clots form in the brain and interrupt blood flow, clogging arteries and causing blood vessels to break, leading to bleeding. Rupture of the arteries leading to the brain during stroke results in the sudden death of brain cells owing to a lack of oxygen. Stroke can also lead to depression and dementia.Cognitive impairment refers to a broad range of deficits in cognitive function, including memory, attention, executive function, language, and visuo-spatial skills. Understanding the connection between stroke and cognitive impairment is crucial for effectively managing symptoms and improving stroke survivors' quality of life.Gamified interventions outperformed conventional therapies in reducing task, completion time , Sustained Engagement. AI-driven adaptive systems, such as the Bright Brainer Grasp (BBG) controller, increased patient motivation by dynamically adjusting difficulty levels based on real-time performance reducing caregiver oversight. BCI and Gamification Synergy , Brain-Computer Interface (BCI) systems combined with gamified tasks (e.g., CoWMeG) improved upper limb motor function. Motor Imagery: Enhanced neural plasticity through imagined movements .Mirror Neuron Activation: Visual feedback from avatars reinforced motor learning..Therefore this study will be designed to investigate the effect of gamification AI based training on cognition in patients with stroke.

Conditions
Stroke
Being tested
AI gamification, conventional therapy
Keywords
Artificial Intelligence Based Gamification Training, Cognition, Functional Outcomes
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AI gamificationOther

    The treatment program for AI gamification group will be in the form of cognitive tasks accompanied by cognitive driven motor tasks ( integrating cognitive strategies into motor tasks) exercises of the upper limb (shoulder, elbow, hand) in the form of AI gamification model. For each patient in study group, session will be for 60 minutes , three times per week for 4 weeks. The patients Will receive AI gamification via VR giving the patient real time feedback, visual and auditory feedback about the range and task .Using this technology we will gain the benefits of both AI and Gamification, the patients will be engaged in the exercise intensively and for a longer time with out getting bored and the tasks will be enjoyable to capture their attention , in addition to traditional training plus conventional therapy

  • conventional therapyOther

    the patiens will receive conventional therapy exercises in the form of flexibility exercises, strengthening exercises, Aerobic training exercise

    • flexibility exercises , it will be in the form of functional stretching for shoulder adductors and flexors, elbow flexors ,wrist and finger flexors
    • strengthening exercises , it will be mainly strengthening exercises for upper limb (shoulder extensors, elbow , wrist and finger extensors) in addition to trunk control exercises targeting proximal stability for distal mobility.

    Aerobic training exercise, as a form of cognitive training exercises

Study groups in NCT07209592
Study groupRoleWhat they receive
AI gamificationExperimentaltwenty patients will receive cognitive tasks accompanied by cognitive-driven motor tasks by AI gamification plus conventional therapy three times per weeks for four weeks
Receives: Other: AI gamification; Other: conventional therapy
conventional therapyActive comparatortwenty patients will receive conventional therapy exercises three times per weeks for four weeks
Receives: Other: conventional therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. cognitive disability

    cognition will be measured by Smart phone- based cognitive assessement allows older adults to be more engaged in cognitive screening and monitoring both inside and outside the clinic. It provide advantages over the traditional cognitive testing such as cost ,time saving, more detailed response metric recordings, automated data collection and scoring.

    Measured: up to four weeks

Secondary outcomes (3)
  1. upper limb function

    Wolf Motor Functional scale will be used for assessment of upper limb function.The original version of the WMFT consisted of 21 items. The widely used version of the WMFT consists of 17 items .It is composed of three parts namely, time, functional ability (items 1-6) and strength (items 7-14). Remaining 9 items involves analysing movement quality when completing various tasks. The less affected side is tested first, followed by the affected limb. The following tasks should be completed as quickly as possible, with a 120-second time limit.

    Measured: up to four weeks

  2. Kinovea motion analysis

    Kinovea for assessment of shoulder ROM and Timing

    Measured: up to four weeks

  3. handgrip strength

    A handheld dynamometer will be used for assessing hand grip strength

    Measured: up to four weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Oct 2025
  2. Study start1 Jan 2026
  3. Primary completion1 Aug 2026
  4. Study completion1 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Artificial Intelligence Based Gamification Training and Exercise Program
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07209592
Sponsor's protocol ID
P.T.REC/012/005963
Acronym
AI
Status last verified
Sep 2026
First submitted
29 Sep 2025
Last updated
16 Sep 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing AI gamification and conventional therapy in people with Stroke, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

cognitive disability (time frame: up to four weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in